Cargando…
Prime editing optimized RTT permits the correction of the c.8713C>T mutation in DMD gene
Duchenne muscular dystrophy is a severe debilitating genetic disease caused by different mutations in the DMD gene leading to the absence of dystrophin protein under the sarcolemma. We used CRISPR-Cas9 prime editing technology for correction of the c.8713C>T mutation in the DMD gene and tested di...
Autores principales: | Happi Mbakam, Cedric, Rousseau, Joel, Lu, Yaoyao, Bigot, Anne, Mamchaoui, Kamel, Mouly, Vincent, Tremblay, Jacques P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587501/ https://www.ncbi.nlm.nih.gov/pubmed/36320324 http://dx.doi.org/10.1016/j.omtn.2022.09.022 |
Ejemplares similares
-
Prime editing strategies to mediate exon skipping in DMD gene
por: Happi Mbakam, Cedric, et al.
Publicado: (2023) -
Prime Editing Permits the Introduction of Specific Mutations in the Gene Responsible for Duchenne Muscular Dystrophy
por: Happi Mbakam, Cédric, et al.
Publicado: (2022) -
Improvements of nuclease and nickase gene modification techniques for the treatment of genetic diseases
por: Lu, Yaoyao, et al.
Publicado: (2022) -
Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
por: Happi Mbakam, Cedric, et al.
Publicado: (2022) -
Small-molecule inhibitors of proteasome increase CjCas9 protein stability
por: Yaméogo, Pouiré, et al.
Publicado: (2023)